Peritonectomy procedures and HIPEC in the treatment of peritoneal carcinomatosis from ovarian cancer: Long-term outcomes and perspectives from a high-volume center-Reference-Cited by-同舟云学术

Peritonectomy procedures and HIPEC in the treatment of peritoneal carcinomatosis from ovarian cancer: Long-term outcomes and perspectives from a high-volume center

Published:2016-02 Issue:2 Volume:42 Page:224-233
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology (EJSO)
language:en
Short-container-title:European Journal of Surgical Oncology (EJSO)

Author:

Muñoz-Casares F.C.,Medina-Fernández F.J.,Arjona-Sánchez Á.,Casado-Adam Á.,Sánchez-Hidalgo J.M.,Rubio M.J.,Ortega-Salas R.,Muñoz-Villanueva M.C.,Rufián-Peña S.,Briceño F.J.

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference36 articles.

1. Cancer statistics, 2014;Siegel;CA Cancer J Clin,2014

2. Treatment goals in ovarian cancer;Ozols;Int J Gynecol Cancer – Off J Int Gynecol Cancer Soc,2005

3. Impact of complete cytoreduction leaving no gross residual disease associated with radical cytoreductive surgical procedures on survival in advanced ovarian cancer;Chang;Ann Surg Oncol,2012

4. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma;Hoskins;Am J Obstet Gynecol,1994

5. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: HIPEC Technologies;Annals of Surgical Oncology;2024-07-22

2. HIPEC application potential in the treatment of extensive carcinomatosis in ovarian cancer (retrospective study);Acta Biomedica Scientifica;2024-06-01

3. The Potential Prognostic Impact of Associated Peritoneal Carcinomatosis in Patients with Stage II and III Epithelial Ovarian Cancer Who Had Upfront Complete Cytoreduction;The Journal of Obstetrics and Gynecology of India;2024-03-25

4. The impact of varying levels of residual disease following cytoreductive surgery on survival outcomes in patients with ovarian cancer: a meta-analysis;BMC Women's Health;2024-03-15

5. Effect of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on epithelial ovarian, fallopian tube, and peritoneal cancer: An institutional review of outcomes and its clinical implications;Philippine Journal of Obstetrics and Gynecology;2024-01